GO:0043546 molybdopterin cofactor binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043546 molybdopterin cofactor binding describes the molecular function of binding a molybdopterin cofactor (Moco), a molybdenum- or tungsten-coordinated pterin that is essential for the catalytic activity of enzymes such as sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase.
• Moco is synthesized through a conserved multistep pathway and is inserted into client enzymes by dedicated chaperone-like proteins, including Cnx1 in plants and gephyrin in mammals.
• Molybdopterin synthase (MOCS2/MOCS3 in humans) carries out the final step of Moco biosynthesis, and mutations that abolish its molybdopterin-binding ability cause molybdenum cofactor deficiency.
• Moco-dependent enzymes participate in purine catabolism, sulfite detoxification, nitrate assimilation, and mitochondrial amidoxime reduction, linking the term to diverse metabolic and disease contexts.
• Moco binding is studied using recombinant protein purification, isothermal titration calorimetry, X-ray crystallography, site-directed mutagenesis, and CRISPR-based knockout or point-mutation cell models.
• Dysregulation of Moco-dependent enzymes is associated with molybdenum cofactor deficiency, xanthinuria, and sulfite oxidase deficiency, making GO:0043546 a relevant target for rare metabolic disease research.
Description
GO:0043546 molybdopterin cofactor binding is a molecular function term that describes the selective, non-covalent interaction between a protein and a molybdopterin cofactor (Moco). Moco is a complex pterin-based cofactor in which a mononuclear molybdenum or tungsten ion is coordinated by one or two molybdopterin ligands, and this cofactor is required for the catalytic activity of a defined set of enzymes, including sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase. Because Moco is not synthesized by the client enzymes themselves, proteins annotated with GO:0043546 typically function as cofactor-binding subunits, insertion factors, or chaperones that receive Moco from the biosynthetic machinery and stabilize it before or during catalysis. For researchers, GO:0043546 provides a precise way to annotate and interrogate the cofactor-binding step that connects Moco biosynthesis to enzyme activation. The term is mechanistically distinct from molybdenum cofactor biosynthesis and from catalytic activity: it captures the binding event itself, which can be measured biochemically and genetically. Mutations that impair Moco binding, such as those in MOCS2 that abolish the molybdopterin-binding ability of molybdopterin synthase, have been characterized in patients with molybdenum cofactor deficiency, illustrating the clinical importance of this function. In this article we integrate the QuickGO definition of GO:0043546 with verified literature to describe the biological process, structural components, molecular mechanism, key genes, disease links, and experimental methods used to study molybdopterin cofactor binding. The content is designed to support both human readers and generative-AI retrieval systems that need accurate, citable information about this GO term.
molybdopterin cofactor binding At A Glance
| GO ID | GO:0043546 |
|---|---|
| GO term | molybdopterin cofactor binding |
| Ontology | molecular_function |
| Synonym | Moco binding |
| Definition | Binding to a molybdopterin cofactor (Moco), essential for the catalytic activity of some enzymes, e.g. sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase; the cofactor consists of a mononuclear molybdenum (Mo-molybdopterin) or tungsten ion (W-molybdopterin) coordinated by one or two molybdopterin ligands. |
| Major function | Cofactor binding and stabilization for Moco-dependent enzymes |
| Representative enzymes | Sulfite oxidase, xanthine dehydrogenase, aldehyde oxidase |
| Related pathway | Molybdenum cofactor biosynthesis and insertion |
| Cofactor composition | Mononuclear Mo or W ion coordinated by one or two molybdopterin ligands |
What Is GO:0043546?
In our own words, GO:0043546 molybdopterin cofactor binding is the molecular function of selectively and reversibly binding a molybdopterin cofactor, a pterin-derived cofactor that coordinates a molybdenum or tungsten ion and is required for the catalytic activity of enzymes such as sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase. The term covers the binding interaction between a protein and Moco, including proteins that receive, stabilize, or insert the cofactor into client enzymes. It does not describe the biosynthesis of Moco itself, nor the catalytic reaction carried out by the Moco-dependent enzyme; rather, it defines the cofactor-binding step that precedes or accompanies catalysis.
Why Is molybdopterin cofactor binding Important in Cell Biology?
GO:0043546 molybdopterin cofactor binding is important because it defines the molecular step that converts an inactive Moco-dependent apoenzyme into a catalytically competent holoenzyme, and because defects in this step cause severe metabolic disease. Moco-dependent enzymes participate in fundamental pathways such as purine catabolism, sulfite detoxification, nitrate assimilation, and mitochondrial amidoxime reduction, so the ability to bind Moco correctly has direct consequences for cellular metabolism and organismal health. In humans, mutations that impair Moco biosynthesis or binding lead to molybdenum cofactor deficiency, a rare but devastating condition characterized by sulfite oxidase deficiency and neurological damage. Studying GO:0043546 therefore informs both basic enzymology and translational research into rare metabolic disorders.
• Moco binding is required for the catalytic activity of sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase, placing GO:0043546 at the center of sulfur and purine metabolism.
• Defects in Moco biosynthesis or binding cause molybdenum cofactor deficiency, a severe inherited metabolic disease with neurological involvement.
• MOCS2 mutations that abolish molybdopterin binding have been characterized in patients, directly linking GO:0043546 to human disease.
• Moco-dependent enzymes such as mARC proteins contribute to mitochondrial amidoxime reduction and drug metabolism.
• In plants and cyanobacteria, Moco binding supports nitrate assimilation and photosynthetic nitrogen metabolism.
• Cnx1G domain mutations in Arabidopsis define distinct functions for molybdopterin binding, molybdenum insertion, and Moco stabilization.
• Molybdopterin dinucleotide transferases in Escherichia coli show nucleotide-specific binding determinants, illustrating the diversity of Moco-related binding functions.
• Cysteine biosynthesis and sulfur metabolism intersect with Moco-dependent sulfite oxidation, connecting GO:0043546 to redox homeostasis.
• GO:0043546 provides a precise annotation target for functional genomics and CRISPR screens of metabolic enzymes.
• Understanding Moco binding supports the development of diagnostic and therapeutic strategies for rare metabolic disorders.
What Happens During molybdopterin cofactor binding?
Moco biosynthesis and maturation
In simple terms: The cell first builds the molybdopterin cofactor through a dedicated pathway before any enzyme can bind it.
Moco is synthesized through a conserved multistep pathway that converts GTP into a pterin-based intermediate, which is then further modified and coordinated with molybdenum or tungsten. In eukaryotes, this pathway involves proteins such as MOCS1, MOCS2, and MOCS3, and the final steps generate the mature molybdopterin cofactor that can be transferred to client enzymes. The biosynthesis and the subsequent binding step are functionally distinct: biosynthesis produces Moco, whereas GO:0043546 describes the binding of the completed cofactor by a recipient protein.
Cofactor transfer and insertion
In simple terms: Dedicated proteins hand the finished cofactor to the enzyme that needs it.
After biosynthesis, Moco is transferred to client enzymes by cofactor-binding and insertion proteins. In plants, the Cnx1G domain binds molybdopterin and is required for molybdenum insertion and Moco stabilization, and mutations in this domain separate molybdopterin binding from downstream steps. In mammals, gephyrin and related proteins participate in Moco insertion into enzymes such as sulfite oxidase and xanthine dehydrogenase. These transfer events are essential because Moco is unstable outside the protected environment of the biosynthetic and insertion machinery.
Binding to client enzymes
In simple terms: The cofactor docks into the target enzyme and stays there to enable catalysis.
Once transferred, Moco binds to the client enzyme, often through a conserved cofactor-binding pocket that coordinates the molybdenum or tungsten ion and the molybdopterin ligand. This binding event is what converts the apoenzyme into an active holoenzyme, and it is the molecular function captured by GO:0043546. Enzymes such as sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase depend on this step for their catalytic activity, and loss of binding results in inactive enzyme.
Stabilization and regulation of the bound state
In simple terms: Once bound, the cofactor and enzyme stabilize each other, and the interaction can be regulated.
Moco binding is not merely a passive docking event; the bound cofactor stabilizes the enzyme and the enzyme protects the cofactor from degradation. Mutations that impair binding, such as the MOCS2 mutation that abolishes the molybdopterin-binding ability of molybdopterin synthase, lead to loss of function and disease. In E. coli, molybdopterin dinucleotide transferases use specific amino acid residues to determine whether guanine or cytosine nucleotides are bound, showing that cofactor-binding specificity is genetically encoded. Together, these observations indicate that Moco binding is a regulated and structurally selective process.
Key Genes Involved in GO:0043546 molybdopterin cofactor binding
The following genes and proteins are directly or functionally associated with molybdopterin cofactor binding (GO:0043546) and its surrounding pathway, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MOCS1 | Moco biosynthesis, early steps | Mutations cause molybdenum cofactor deficiency |
| MOCS2 | Molybdopterin synthase subunit; molybdopterin binding | Mutations abolish molybdopterin binding and cause disease |
| MOCS3 | Molybdopterin synthase sulfurtransferase | Supports Moco biosynthesis and maturation |
| GPHN | Gephyrin; Moco insertion and receptor clustering | Links Moco binding to neuronal function |
| SUOX | Sulfite oxidase; Moco-dependent enzyme | Deficiency causes sulfite oxidase deficiency |
| XDH | Xanthine dehydrogenase; Moco-dependent enzyme | Deficiency causes xanthinuria |
| AOX1 | Aldehyde oxidase; Moco-dependent enzyme | Drug metabolism and reactive oxygen species |
| MTARC1 | Mitochondrial amidoxime reducing component 1 | Moco-dependent drug and lipid metabolism |
| MTARC2 | Mitochondrial amidoxime reducing component 2 | Moco-dependent drug and lipid metabolism |
| CNX1 | Plant Moco insertion protein; molybdopterin binding | Model for Moco binding and insertion |
| CNX2 | Plant Moco biosynthesis | Moco pathway in Arabidopsis |
| NARB | Nitrate reductase accessory protein in cyanobacteria | Nitrate assimilation and Moco binding |
| MOAE | Molybdopterin dinucleotide transferase in E. coli | Nucleotide specificity of Moco binding |
| MOBD | Molybdopterin dinucleotide transferase in E. coli | Nucleotide specificity of Moco binding |
| CysK | Cysteine biosynthesis; sulfur metabolism | Intersects with sulfite and Moco metabolism |
| CysM | Cysteine biosynthesis; sulfur metabolism | Intersects with sulfite and Moco metabolism |
| TAT | Twin-arginine translocation pathway | Protein export relevant to Moco enzyme maturation |
How Is molybdopterin cofactor binding Regulated?
Molybdopterin cofactor binding is regulated at multiple levels. The availability of Moco is controlled by the expression and activity of the biosynthesis enzymes MOCS1, MOCS2, and MOCS3, and mutations in these genes directly affect the amount of cofactor available for binding. In plants, the Cnx1G domain couples molybdopterin binding to molybdenum insertion and Moco stabilization, so the binding step is functionally linked to cofactor maturation. In E. coli, molybdopterin dinucleotide transferases use specific residues to discriminate between guanine and cytosine nucleotides, showing that binding specificity is genetically determined. In cyanobacteria, nitrate assimilation and photosynthetic nitrogen metabolism influence the demand for Moco-dependent enzymes, indirectly regulating the pathway. Cysteine biosynthesis and sulfur metabolism also intersect with sulfite oxidation, providing a metabolic context in which Moco binding is required.
molybdopterin cofactor binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MOCS1 | Molybdenum cofactor deficiency | Knockout cell model; patient-derived fibroblasts |
| MOCS2 | Molybdenum cofactor deficiency; abolished molybdopterin binding | Point-mutation knock-in; recombinant protein binding assay |
| SUOX | Sulfite oxidase deficiency | Knockout and overexpression cell models |
| XDH | Xanthinuria; purine catabolism | Knockout cell model; metabolite profiling |
| MTARC1/MTARC2 | Drug metabolism; amidoxime reduction | Overexpression and knockout models |
Molybdenum cofactor deficiency
Molybdenum cofactor deficiency is a rare inherited metabolic disorder caused by defects in Moco biosynthesis, leading to combined deficiency of sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase. Mutations in MOCS1 and MOCS2, including a MOCS2 mutation that abolishes the molybdopterin-binding ability of molybdopterin synthase, have been identified in patients. Because GO:0043546 describes the cofactor-binding step, loss of Moco binding is a direct molecular mechanism underlying this disease.
Sulfite oxidase deficiency and neurological damage
Sulfite oxidase is a Moco-dependent enzyme that detoxifies sulfite, and its deficiency leads to accumulation of sulfite and severe neurological damage. Because sulfite oxidase requires Moco binding for activity, defects in GO:0043546-related proteins can phenocopy sulfite oxidase deficiency. This connection makes Moco binding a relevant research target for understanding sulfur metabolism and neuroprotection.
Xanthinuria and purine metabolism
Xanthine dehydrogenase is a Moco-dependent enzyme involved in purine catabolism, and its deficiency causes xanthinuria. Loss of Moco binding impairs xanthine dehydrogenase activity, leading to accumulation of xanthine and related metabolites. This links GO:0043546 to purine metabolism disorders and to the broader study of Moco-dependent enzymes.
Drug metabolism and mitochondrial amidoxime reduction
The mARC proteins MTARC1 and MTARC2 are Moco-dependent enzymes that reduce amidoximes and contribute to drug metabolism. Their activity depends on Moco binding, so GO:0043546 is relevant to pharmacology and to understanding interindividual variability in drug response. This connection expands the disease relevance of Moco binding beyond classic metabolic disorders.
From molybdopterin cofactor binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MOCS2 abolish molybdopterin binding? | Point-mutation knock-in cell line |
| Is a candidate gene required for Moco-dependent enzyme activity? | CRISPR knockout cell model |
| Can a disease-associated mutation be corrected? | Knock-in of wild-type allele; isogenic controls |
| Where does the Moco-binding protein localize? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression of a Moco-binding protein increase enzyme activity? | Overexpression cell model |
| Which genes modify Moco binding in a genome-wide screen? | CRISPR library screening |
How to Study the molybdopterin cofactor binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isothermal titration calorimetry | Binding affinity and stoichiometry | Cofactor binding by purified proteins |
| X-ray crystallography | Three-dimensional structure of the binding pocket | Mechanistic studies of Moco binding |
| Site-directed mutagenesis | Effect of specific residues on binding | Testing disease-associated mutations |
| CRISPR knockout | Requirement of a gene for Moco-dependent activity | Functional genomics of Moco pathway |
| CRISPR point mutation | Effect of a specific variant on binding | Modeling patient mutations |
| Metabolomics | Levels of sulfite, xanthine, and related metabolites | Assessing Moco-dependent enzyme activity |
| Proteomics | Expression and stability of Moco-binding proteins | Pathway and network analysis |
| Fluorescence imaging | Subcellular localization of tagged proteins | Studying Moco insertion and trafficking |
Biochemical binding assays
Recombinant expression and purification of Moco-binding proteins followed by isothermal titration calorimetry, surface plasmon resonance, or radioligand binding can directly measure cofactor binding affinity and specificity. These assays are used to test whether mutations such as those in MOCS2 abolish molybdopterin binding.
Structural biology
X-ray crystallography and cryo-electron microscopy can resolve the cofactor-binding pocket and the coordination geometry of the molybdenum or tungsten ion. Structural studies of Cnx1G and molybdopterin dinucleotide transferases have defined the residues that determine nucleotide and cofactor specificity.
Genetic and CRISPR screens
CRISPR knockout and point-mutation cell models can be used to test the requirement for candidate genes in Moco binding and Moco-dependent enzyme activity. Pooled CRISPR library screening can identify modifiers of Moco-dependent phenotypes and pathways.
Metabolic and proteomic profiling
Metabolomics can quantify sulfite, xanthine, and related metabolites to infer Moco-dependent enzyme activity, while proteomics can assess expression and stability of Moco-binding proteins. These approaches link molecular binding events to cellular and organismal phenotypes.
How CRISPR Can Be Used to Study GO:0043546 molybdopterin cofactor binding
Knockout
CRISPR knockout of MOCS1, MOCS2, or client enzymes such as SUOX and XDH can be used to eliminate Moco binding and measure the resulting loss of enzyme activity and metabolic consequences. Knockout cell models are valuable for confirming that a candidate gene is required for Moco-dependent pathways.
Point Mutation
CRISPR point mutation can introduce disease-associated variants, such as the MOCS2 mutation that abolishes molybdopterin binding, into isogenic cell lines. These models allow precise testing of whether a specific amino acid change impairs cofactor binding without confounding effects from complete gene loss.
Knock-in
Knock-in of wild-type or tagged alleles can restore or visualize Moco-binding proteins in a physiological context. Tagged knock-in models are particularly useful for localization and interaction studies of Moco insertion factors such as Cnx1G.
Overexpression
Overexpression of Moco-binding proteins or client enzymes can be used to test whether increased cofactor binding capacity enhances enzyme activity or alters metabolic flux. Overexpression models are also useful for producing recombinant protein for biochemical and structural studies.
How EDITGENE Supports molybdopterin cofactor binding Research
Researchers studying molybdopterin cofactor binding-related genes often need to determine whether a candidate gene is causally involved in cofactor binding, enzyme activation, or disease phenotypes. EDITGENE provides publication-ready CRISPR cell models and screening services that allow precise interrogation of GO:0043546-related biology, from single-gene knockouts to genome-wide library screens.
Contact EDITGENE today to design your custom CRISPR model for molybdopterin cofactor binding research.
Frequently Asked Questions About molybdopterin cofactor binding
What is molybdopterin cofactor binding?
Molybdopterin cofactor binding (GO:0043546) is the molecular function of binding a molybdopterin cofactor, a pterin-based cofactor that coordinates a molybdenum or tungsten ion and is required for the activity of enzymes such as sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase.
What genes are involved in molybdopterin cofactor binding?
Genes involved include MOCS1, MOCS2, MOCS3, GPHN, SUOX, XDH, AOX1, MTARC1, MTARC2, and plant CNX1, as well as bacterial molybdopterin dinucleotide transferases.
What is the GO ID for molybdopterin cofactor binding?
The GO ID is GO:0043546, and the official term name is molybdopterin cofactor binding.
What diseases are associated with molybdopterin cofactor binding defects?
Defects are associated with molybdenum cofactor deficiency, sulfite oxidase deficiency, xanthinuria, and related metabolic disorders.
Which enzymes require molybdopterin cofactor binding?
Sulfite oxidase, xanthine dehydrogenase, aldehyde oxidase, and mitochondrial amidoxime reducing components require Moco binding for catalytic activity.
How is molybdopterin cofactor binding studied?
It is studied using recombinant protein binding assays, X-ray crystallography, site-directed mutagenesis, CRISPR knockout and point-mutation models, metabolomics, and proteomics.
What happens when molybdopterin cofactor binding is lost?
Loss of binding inactivates Moco-dependent enzymes, leading to accumulation of substrates such as sulfite and xanthine and to metabolic disease.
Is molybdopterin cofactor binding the same as molybdenum cofactor biosynthesis?
No, biosynthesis produces the cofactor, whereas GO:0043546 describes the binding of the completed cofactor by a recipient protein.
Can CRISPR be used to study molybdopterin cofactor binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to test the role of specific genes and variants in Moco binding.
What model systems are used for molybdopterin cofactor binding research?
Common models include human cell lines, Arabidopsis, Escherichia coli, and cyanobacteria, depending on the specific question.
Conclusion
GO:0043546 molybdopterin cofactor binding defines the essential molecular step in which a molybdopterin cofactor is bound by a recipient protein, enabling the catalytic activity of enzymes such as sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase. The term is mechanistically distinct from cofactor biosynthesis and is directly linked to human disease through mutations that abolish binding, as shown for MOCS2. Understanding this function requires integrating structural, biochemical, and genetic approaches, including CRISPR-based cell models and screening. For researchers, GO:0043546 provides a precise annotation and experimental target for studying metabolic enzymes, rare metabolic disorders, and cofactor-dependent pathways. EDITGENE supports this research with custom CRISPR knockout, point-mutation, knock-in, overexpression, and library screening services tailored to molybdopterin cofactor binding biology.
References
- 1. Mendel RR. 2013. The molybdenum cofactor.. J Biol Chem 288(19):13165-72 PMID: 23539623
- 2. Leimkühler S et al.. 2005. Ten novel mutations in the molybdenum cofactor genes MOCS1 and MOCS2 and in vitro characterization of a MOCS2 mutation that abolishes the binding ability of molybdopterin synthase.. Hum Genet 117(6):565-70 PMID: 16021469
- 3. Ott G et al.. 2015. The mammalian molybdenum enzymes of mARC.. J Biol Inorg Chem 20(2):265-75 PMID: 25425164
- 4. Hutcheon GW et al.. 2003. The archaeal twin-arginine translocation pathway.. Biochem Soc Trans 31(Pt 3):686-9 PMID: 12773183
- 5. Kuper J et al.. 2000. Mutations in the molybdenum cofactor biosynthetic protein Cnx1G from Arabidopsis thaliana define functions for molybdopterin binding, molybdenum insertion, and molybdenum cofactor stabilization.. Proc Natl Acad Sci U S A 97(12):6475-80 PMID: 10823911
- 6. Neumann M et al.. 2011. Molybdopterin dinucleotide biosynthesis in Escherichia coli: identification of amino acid residues of molybdopterin dinucleotide transferases that determine specificity for binding of guanine or cytosine nucleotides.. J Biol Chem 286(2):1400-8 PMID: 21081498
- 7. Flores E et al.. 2005. Photosynthetic nitrate assimilation in cyanobacteria.. Photosynth Res 83(2):117-33 PMID: 16143847
- 8. Kredich NM. 2008. Biosynthesis of Cysteine.. EcoSal Plus 3(1) PMID: 26443742
